In vitro studies of skin fibroblasts from a patient with a new type of primary cortisol resistance: glucocorticoid receptor status and glucocorticoid effect on DNA synthesis. 1987

M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui

Studies made on cultured skin fibroblasts obtained from a patient with primary cortisol resistance are described. Whole cell in vitro assays, using the patient's fibroblasts revealed a reduction in the dexamethasone binding capacity (7.86 +/- 0.73 fmol/micrograms DNA, mean +/- SD, n = 3; normal: 15.2 +/- 1.90 fmol/micrograms DNA, n = 8) and an apparently normal dissociation constant (3.69 +/- 0.15 nM; normal: 3.74 +/- 0.40 nM). In addition, the effects of glucocorticoids on DNA synthesis in these cells were examined. DNA synthesis was inhibited by dexamethasone both in normal fibroblasts and in the patient's cells, but the patient's cells were less sensitive to this inhibition, indicating resistance of the cells to glucocorticoid in vitro. These results suggest that the resistance of target tissues to glucocorticoids is due to the reduction in receptor number and that this is the primary defect in this new type of primary cortisol resistance in man.

UI MeSH Term Description Entries
D008297 Male Males
D011965 Receptors, Glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Corticoid Type II Receptor,Glucocorticoid Receptors,Glucocorticoids Receptor,Corticoid II Receptor,Corticoid Type II Receptors,Glucocorticoid Receptor,Receptors, Corticoid II,Receptors, Corticoid Type II,Receptors, Glucocorticoids,Corticoid II Receptors,Glucocorticoids Receptors,Receptor, Corticoid II,Receptor, Glucocorticoid,Receptor, Glucocorticoids
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
November 1991, The Journal of steroid biochemistry and molecular biology,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
August 1987, The Journal of clinical endocrinology and metabolism,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
January 1990, Transactions of the Association of American Physicians,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
May 1993, The Journal of clinical investigation,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
June 1982, The Journal of clinical investigation,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
February 1989, Journal of steroid biochemistry,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
November 1986, The Journal of clinical investigation,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
June 1979, Journal of steroid biochemistry,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
March 1994, Agents and actions,
M Gomi, and S Iida, and M Tsugawa, and Y Itoh, and K Moriwaki, and H Fujii, and S Yamashita, and T Tamaki, and S Tarui
January 1990, Medicina cutanea ibero-latino-americana,
Copied contents to your clipboard!